ReleaseWire

NASDAQ:FMI Shareholder Alert: Investigation of Potential Wrongdoing at Foundation Medicine Inc

An investigation on behalf of current long term investors in Foundation Medicine Inc (NASDAQ:FMI) shares over possible breaches of fiduciary duty by certain officers and directors was announced and NASDAQ:FMI stockholders should contact the Shareholders Foundation.

Posted: Wednesday, November 01, 2017 at 11:00 AM CDT

San Diego, CA -- (SBWire) -- 11/01/2017 --An investigation was announced for investors in NASDAQ:FMI shares over potential breaches of fiduciary duties by certain directors.

Investors in Foundation Medicine Inc (NASDAQ:FMI) shares should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.

The investigation by a law firm for investors in NASDAQ:FMI stocks follows a lawsuit filed recently against Foundation Medicine Inc over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ:FMI stocks, concerns whether certain Foundation Medicine Inc officers and directors are liable in connection with the allegations made in that lawsuit. The plaintiff alleges that the defendants made false and/or misleading statements regarding the reimbursement process and likelihood of coverage for Foundation's tumor tests by Medicare and the Company's financial guidance.

Those who purchased shares of Foundation Medicine Inc (NASDAQ:FMI) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com